Clinical laboratory identification of liposomal cytarabine in cerebrospinal fluid.
Diane
D
Mangraviti
Jonathan R
JR
Genzen
D000368:Aged; D016477:Artifacts; D002498:Centrifugation; D002555:Cerebrospinal Fluid / Q000737:chemistry* / Q000166:cytology; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D011232:Chemical Precipitation; D003561:Cytarabine / Q000008:administration & dosage / Q000032:analysis*; D003692:Delayed-Action Preparations; D004912:Erythrocytes; D005947:Glucose / Q000134:cerebrospinal fluid; D006801:Humans; D007278:Injections, Spinal; D008081:Liposomes / Q000648:ultrastructure*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D008297:Male; D010316:Particle Size; D013194:Staining and Labeling
D002556:Cerebrospinal Fluid Proteins; D003692:Delayed-Action Preparations; D008081:Liposomes; D003561:Cytarabine; D005947:Glucose